02/22/2012
Federal Register Notice: CDER is announcing the continuation of the Regulatory Project Management Site Tours and Regulatory Intera...02/22/2012
Federal Register Notice: FDA is issuing an order under the FD&C Act permanently debarring Stephen L. Marks from providing services...02/22/2012
Federal Register Notice: FDA is making available final product-specific bioequivalence (BE) recommendations that provide guidance ...02/16/2012
Federal Register Notice: FDA is sponsoring a workshop 3/7 entitled, “Design and Methodology for Postmarket Surveillance Stud...02/10/2012
Federal Register Notice: FDA’s proposed collection of information, “Medical Device Recall Authority —21 CFR Part...02/10/2012
Federal Register Notice: FDA is making available a draft guidance for industry, Determining the Extent of Safety Data Collection N...02/06/2012
Federal Register Notice: FDA’s Oncologic Drugs Advisory Committee will meet 3/21, from 8 a.m. to 12:45 p.m. at the FDA White...02/06/2012
Federal Register Final rule: FDA is adopting as a final rule, without change, the interim final rule that issued regulations permi...